Henry Schein Buys Vaccine Supplier

Share this content:
Healthcare products direct marketer Henry Schein Inc., Melville, NY, announced Dec. 29 that it will acquire General Injectables and Vaccines for $65 million in cash and up to $80 million in additional sales incentives. The acquisition of GIV, Bastian, VA, is Schein's sixth of 1998 and fourth in the United States. The direct-to-physician supplier also has purchased Bedsole Medical Co., Mobile, AL, Columbia Medical, Columbia, MD, and Meer Dental Supply, Canton, MI, with combined annual revenues of $217 million. GIV's annual revenues for 1998 are an estimated $118 million. GIV will become part of Schein's Medical Group but will operate as a stand-alone company. It distributes vaccines to 32,000 medical office customers through a 50-person call center that handles more than 1 million calls per year. The acquisition expands Schein's position in the vaccine market, which CEO Stanley Bergman predicts will see annual growth of 15 percent for the next five years.

Sign up to our newsletters

Company of the Week

USAData helps businesses find new customers and grow their current customers through a combination of data and digital marketing services, and easy-to-use SaaS technology products. We enrich customer data so businesses can more effectively target and communicate with customers, and connect them with their best look-alike prospects through digital and traditional channels. We make it easy through simple, self-serve applications and APIs, as well as through full-service programs managed by our Data and Digital experts. 

Find out more here »

Career Center

Check out hundreds of exciting professional opportunities available on DMN's Career Center.  
Explore careers in digital marketing, sales, eCommerce, marketing communications, IT, data strategies, and much more. And don't forget to update your resume so employers can contact you privately about job opportunities.

>>Click Here

Relive the 2017 Marketing Hall of Femme

Click the image above